基石药业-B授出480万份购股权及193万份受限制股份单位

Group 1 - The company, Basestone Pharmaceuticals-B (02616), announced the grant of a total of 4.8 million stock options to 5 option grantees for the subscription of 4.8 million shares as part of its employee shareholding plan post-initial public offering [1] - Additionally, the company granted a total of 1.93 million restricted share units to 5 restricted share unit grantees under its post-initial public offering restricted share award plan, subject to acceptance by the grantees [1]